Identification of frailty and sarcopenia in hospitalised older people.
Iñaki EcheverriaAriadna BesgaBegoña SanzMaria AmaseneGotzone HervásJulia BarrosoAna Rodriguez LarradJon IrazustaPublished in: European journal of clinical investigation (2020)
Myostatin may be a useful biomarker for sarcopenia in post-hospitalised older adults. However, it has a lower capability for identifying frailty than physical tests. Further studies using larger samples and these myokines together with other biomarkers are warranted.